Page 79 - 18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation
P. 79
CHAPTER 4
Interobserver Agreement of Interim and End-of-Treatment 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and Trials.
Coreline N. Burggraaff Otto S. Hoekstra Bart de Keizer Filiz Celik Henrica C.W. de Vet
Alexander C. Cornelisse Pieternella J. Lugtenburg Anne I.J. Arens Julia E. Huijbregts Josée M. Zijlstra
On behalf of the HOVON Imaging Working Group
Journal of Nuclear Medicine 2018; 59: 1831-1836.
